Guselkumab Approved for PsA
FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
Simple Tasks
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
ACR Convergence
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.